According to Gram Research analysis, a traditional Chinese herbal formula called Qi Wei Zhi Gan may help prevent liver scarring in people with fatty liver disease by blocking a protein called Peroxidasin that normally glues collagen together. In laboratory studies using mice and human tissue samples, the herbal mixture reduced liver scarring and inflammation by interrupting this collagen-sticking process. However, these findings are preliminary and haven’t yet been tested in human patients, so this isn’t yet a proven treatment.
Researchers discovered that a traditional Chinese herbal formula called Qi Wei Zhi Gan (QWZG) may help prevent liver scarring in people with a serious fatty liver disease called MASH. Using laboratory mice and human tissue samples, scientists found that the herbal mixture works by blocking a specific protein that causes collagen buildup in the liver. This protein, called Peroxidasin, acts like a glue that sticks collagen together, leading to scarring. When the herbal formula blocked this protein, the liver showed less damage and inflammation. While these results are promising, more human studies are needed before doctors can recommend this treatment to patients.
Key Statistics
A 2026 research study found that the herbal formula Qi Wei Zhi Gan reduced liver scarring in mice by blocking Peroxidasin, a protein that acts as molecular glue for collagen buildup in damaged liver tissue.
Human tissue analysis in the 2026 study showed a strong association between Peroxidasin expression levels and the severity of liver fibrosis, suggesting the protein’s role in scarring is relevant to actual human disease.
The herbal formula reduced multiple scarring markers including αSMA and Col1a1 expression in laboratory studies, indicating it suppresses the activation of liver cells responsible for producing excessive collagen.
The Quick Take
- What they studied: Whether a traditional Chinese herbal mixture could stop or slow liver scarring in people with metabolic dysfunction-associated steatohepatitis (MASH), a serious fatty liver disease
- Who participated: Laboratory mice fed a special diet to develop fatty liver disease, plus human tissue samples analyzed using advanced genetic sequencing techniques
- Key finding: The herbal formula Qi Wei Zhi Gan reduced liver scarring by blocking a protein called Peroxidasin that normally glues collagen together in damaged liver tissue
- What it means for you: This research suggests a potential new treatment for fatty liver disease, but it’s still in early stages. People with MASH should continue following their doctor’s advice about diet and exercise while researchers work toward human trials
The Research Details
Scientists conducted a multi-layered investigation starting with laboratory mice. They fed some mice a special diet that causes fatty liver disease similar to MASH in humans. These mice then received the herbal formula while others didn’t, allowing researchers to compare outcomes. The team measured liver damage, inflammation, and fat buildup using blood tests and tissue examination.
To understand how the formula worked, researchers used advanced technology called proteomics to identify which proteins changed when the formula was given. They then tested these findings in liver cells grown in the laboratory and confirmed results using genetic analysis. Finally, they used human tissue samples and cutting-edge genetic sequencing to verify that their findings applied to real human livers with scarring.
This approach—starting with animal models, moving to cell cultures, and confirming with human tissue—is considered a strong research design because it builds evidence from multiple angles before human testing would occur.
This research approach is important because it identifies not just that a treatment works, but specifically how it works at the molecular level. Understanding the mechanism—in this case, blocking Peroxidasin protein—helps scientists design better treatments and predict which patients might benefit most. The use of human tissue samples at the end strengthens confidence that findings aren’t just laboratory curiosities but may actually apply to real patients.
Strengths include the use of multiple research methods (animal studies, cell cultures, and human tissue analysis) that all pointed to the same conclusion, suggesting the findings are reliable. The study was published in a peer-reviewed scientific journal, meaning other experts reviewed it before publication. Limitations include that this work was done in laboratories and mice, not yet in living humans, so results may not translate directly to patient treatment. The exact sample sizes for some experiments weren’t clearly specified in the abstract, and the study doesn’t yet include clinical trials in human patients.
What the Results Show
The herbal formula Qi Wei Zhi Gan produced several important effects in mice with fatty liver disease. First, it reduced obesity and liver enlargement, and it decreased the amount of fat accumulating in liver cells. The formula also reduced inflammation markers, suggesting it calmed the immune system’s overreaction in the damaged liver.
Most importantly, the formula blocked a specific protein called Peroxidasin (Pxdn) that acts like molecular glue. This protein normally sticks collagen molecules together, creating the stiff, scarred tissue that characterizes advanced liver disease. When Peroxidasin was blocked, collagen didn’t accumulate as much, and the liver showed less scarring.
The researchers confirmed this mechanism by deliberately increasing Peroxidasin levels in some mice using genetic engineering. These mice developed more liver scarring, but when given the herbal formula, the scarring was reduced. This back-and-forth experiment strongly suggests that blocking Peroxidasin is genuinely how the formula helps prevent liver damage.
Analysis of human liver tissue samples showed that Peroxidasin levels were strongly linked to how severe the liver scarring was, supporting the idea that this mechanism is relevant to actual human disease.
Beyond the main findings, the research showed that the herbal formula reduced markers of hepatic stellate cell activation. These are special cells that, when activated, produce excessive collagen and cause scarring. The formula also decreased expression of Col1a1 and αSMA, which are proteins associated with the scarring process. These secondary findings all point in the same direction: the formula reduces multiple aspects of the scarring cascade.
This research builds on previous knowledge that Qi Wei Zhi Gan has some benefit for fatty liver disease, but it’s the first to identify Peroxidasin and collagen crosslinking as the specific mechanism. Previous studies showed the formula helped with inflammation and fat accumulation, but didn’t explain why. By identifying Peroxidasin as the key target, this research provides a more complete picture and suggests why the formula is effective. The findings align with emerging research showing that collagen crosslinking is a critical step in liver scarring that could be targeted therapeutically.
The most significant limitation is that all experiments were conducted in mice or laboratory settings—not in living human patients. Mouse livers don’t perfectly mirror human livers, so results may not translate directly. The study didn’t include a human clinical trial, which is necessary before doctors could recommend this treatment. Additionally, the exact doses and duration of treatment that would be safe and effective in humans remain unknown. The research also doesn’t address whether the formula would work for people with advanced cirrhosis or other liver conditions. Finally, while the herbal formula contains multiple ingredients, the study doesn’t clearly identify which specific herbs are responsible for the benefits.
The Bottom Line
Based on this research, the herbal formula Qi Wei Zhi Gan shows promise as a potential treatment for fatty liver disease, but it’s not yet ready for clinical use (confidence level: preliminary). People with MASH should continue following established medical advice: maintain a healthy weight, eat a balanced diet low in processed foods, exercise regularly, and work with their doctor on an individualized treatment plan. Do not self-treat with herbal formulas without medical supervision, as some herbs can interact with medications or cause liver damage themselves.
This research is most relevant to people with metabolic dysfunction-associated steatohepatitis (MASH), formerly called non-alcoholic fatty liver disease (NAFLD). It’s also of interest to researchers and pharmaceutical companies developing new liver disease treatments. People with early-stage fatty liver disease may find this encouraging, but should understand it’s not yet a proven treatment. Those with advanced cirrhosis should discuss with their doctor whether this research might eventually apply to them. People without liver disease don’t need to act on this research currently.
Based on typical drug development timelines, if this herbal formula moves forward, human clinical trials would likely take 3-5 years minimum. Even if trials are successful, regulatory approval and availability could take several additional years. Realistic expectations: this research is a promising early step, but patients shouldn’t expect this specific treatment to be available for at least 5-10 years. In the meantime, proven lifestyle modifications remain the most effective approach.
Frequently Asked Questions
Can I take Qi Wei Zhi Gan herbal formula to treat my fatty liver disease?
Not yet based on current evidence. While laboratory research shows promise, human clinical trials haven’t been conducted. Talk to your doctor before taking any herbal supplements, as some can interact with medications or harm the liver. Proven treatments include weight loss, exercise, and reducing processed foods.
How does Peroxidasin cause liver scarring?
Peroxidasin acts like molecular glue, sticking collagen molecules together to form stiff, scarred tissue in the liver. When this protein is blocked, collagen doesn’t accumulate as much, reducing scarring. The herbal formula works by suppressing this protein’s activity.
When will this herbal treatment be available for patients?
This research is in early stages. Human clinical trials would typically take 3-5 years minimum, with regulatory approval adding several more years. Realistic timeline: 5-10 years before this specific treatment might become available, if trials are successful.
Does this research apply to all types of liver disease?
This study specifically examined metabolic dysfunction-associated steatohepatitis (MASH), a fatty liver disease. It may eventually apply to other liver conditions involving scarring, but that hasn’t been tested yet. People with other liver diseases should consult their doctor about relevance.
What should I do right now if I have fatty liver disease?
Follow proven strategies: maintain a healthy weight, exercise 30 minutes most days, eat a balanced diet low in processed foods and added sugars, and work with your doctor on monitoring. These approaches are proven effective and don’t require waiting for new treatments to be developed.
Want to Apply This Research?
- Users with fatty liver disease should track liver health markers that their doctor monitors: ALT and AST levels (liver enzymes), triglycerides, and weight. Monthly tracking of these metrics in the app, synced with doctor visits, helps visualize progress and identify trends that might indicate improvement or worsening.
- Users can set daily goals for the three proven interventions for fatty liver disease: 30 minutes of moderate exercise, reducing processed food intake to under 10% of daily calories, and achieving a 5-10% weight loss if overweight. The app can send reminders and track progress toward these evidence-based lifestyle changes while users await future clinical trials of herbal treatments.
- Establish a quarterly check-in system where users log their latest liver function test results from their doctor, weight, exercise frequency, and diet quality. The app can generate trend reports showing whether these metrics are improving, stable, or worsening, helping users and their doctors assess whether current interventions are working and whether new approaches (like future clinical trials) might be appropriate.
This article summarizes preliminary laboratory research and has not been tested in human patients. The herbal formula discussed is not yet approved by the FDA or other regulatory agencies for treating liver disease. This information is educational only and should not be used to self-diagnose or self-treat. Anyone with fatty liver disease or liver concerns should work with a qualified healthcare provider. Do not start, stop, or change any herbal supplements without consulting your doctor, as some herbs can interact with medications or cause liver damage. This research represents early-stage science and may not translate to human treatment.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.